Search research articles
Contact Us
Filters
Showing results (281-290 of 391) with videos related to
Page
of 40
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1994
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine
B Merola, F Sarnacchiaro, A Colao, et al.
Endocrine
|
March 30, 2011
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism
A Faggiano, C Di Somma, V Ramundo, et al.
Journal of Endocrinological Investigation
|
July 3, 2010
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues
M C De Martino, R S Auriemma, G Brevetti, et al.
Metabolism: Clinical and Experimental
|
August 1, 1996
Cardiovascular aspects in acromegaly: effects of treatment
G Lombardi, A Colao, D Ferone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic states
B Merola, F Sarnacchiaro, A Colao, et al.
Endocrine
|
August 24, 2014
ACROSTUDY: the Italian experience
S Grottoli, P Maffei, F Bogazzi, et al.
Journal of Endocrinological Investigation
|
July 11, 2012
Beyond waist circumference in an adult male population of Southern Italy: Is there any role for subscapular skinfold thickness in the relationship between insulin-like growth factor-I system and metabolic parameters?
S Savastano, A Barbato, C Di Somma, et al.
Minerva Endocrinologica
|
April 5, 2011
Thyroid function in Fabry disease before and after enzyme replacement therapy
A Faggiano, R Severino, V Ramundo, et al.
The New England Journal of Medicine
|
January 23, 1997
Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone
G Palmieri, S Lastoria, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 14, 1997
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage
A Colao, A Di Sarno, M L Landi, et al.
Page
of 40
Search research articles
Search
Showing results (281-290 of 391) with videos related to
Sort By:
Page
of 40
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1994
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine
B Merola, F Sarnacchiaro, A Colao, et al.
Endocrine
|
March 30, 2011
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism
A Faggiano, C Di Somma, V Ramundo, et al.
Journal of Endocrinological Investigation
|
July 3, 2010
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues
M C De Martino, R S Auriemma, G Brevetti, et al.
Metabolism: Clinical and Experimental
|
August 1, 1996
Cardiovascular aspects in acromegaly: effects of treatment
G Lombardi, A Colao, D Ferone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic states
B Merola, F Sarnacchiaro, A Colao, et al.
Endocrine
|
August 24, 2014
ACROSTUDY: the Italian experience
S Grottoli, P Maffei, F Bogazzi, et al.
Journal of Endocrinological Investigation
|
July 11, 2012
Beyond waist circumference in an adult male population of Southern Italy: Is there any role for subscapular skinfold thickness in the relationship between insulin-like growth factor-I system and metabolic parameters?
S Savastano, A Barbato, C Di Somma, et al.
Minerva Endocrinologica
|
April 5, 2011
Thyroid function in Fabry disease before and after enzyme replacement therapy
A Faggiano, R Severino, V Ramundo, et al.
The New England Journal of Medicine
|
January 23, 1997
Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone
G Palmieri, S Lastoria, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 14, 1997
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage
A Colao, A Di Sarno, M L Landi, et al.
Page
of 40